~~<i id='DF1F8B3637'><strike id='DF1F8B3637'><tt id='DF1F8B3637'><pre id='DF1F8B3637'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

hotspot

author：explore 2025-09-27 23:52:58 - browse：8468

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： American woman kidnapped in Mexico freed after 8 months in captivity: FBI

focus

hotspot

explore

Wikipedia

hotspot

8:04Astheir5-year-olddaughterbattlesararegeneticdisorder,GillianandRockySapia,struggledtogettogetthe

WSS

Reanimated hearts work just as well for transplants, study finds

Patients, doctors are clashing about side effects of hormonal birth control

Why police arrested suspected Gilgo Beach killer away from his house

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Patients, doctors are clashing about side effects of hormonal birth control

Woman gored by Bison at Yellowstone

entertainment

hotspot

focus

Apple is now the first public company to be valued at $3 trillion

Timeline: Key moments in fight for gay rights

New air purifier tech could be key to improving indoor air quality

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Trump demands the U.S. pay no more for drugs than other countries … again

Inside the rise of 'mukbang' eating videos

Walensky prepares to leave CDC — and Congress — behind

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Apple is now the first public company to be valued at $3 trillion

Involuntary treatment for addiction doesn't work

hotspot

A public health expert passes on football's full body collisions for youths

Altering the blood type of lungs raises potential for universal organs for transplants

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Biden administration plans revamp of organ transplant system

Mike Pence clashes with Tucker Carlson in Iowa

Celiac disease study examines precisely how gluten triggers injury

explore

Wikipedia

hotspot

hotspot